Intravenous Administration of Zoledronate in Children with Bone-Associated Langerhans Cell Histiocytosis - Top-Institutions - MDSpire

Intravenous Administration of Zoledronate in Children with Bone-Associated Langerhans Cell Histiocytosis

  • By

  • Sy, Jann Adriel

  • Quah, Thuan Chong

  • Tee, Pian Pian

  • Ho, Cindy Wei Li

  • April 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Bone Disease
    • Rare Pediatric Disorders
  • #2

    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center

    Boston, MA

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Bone Metabolism
    • Histiocytosis
  • #3

    National University Hospital
    National University Hospital

    Singapore, Singapore

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Bone Disease
    • Histiocytosis
  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Bone Disease
    • Rare Cancers
  • #5

    Great Ormond Street Hospital for Children
    Great Ormond Street Hospital for Children

    London, England

    Key Differentiators

    • Pediatric Hematology-Oncology
    • Bone Disorders
    • Rare Pediatric Diseases

Original Source(s)

Related Content